Inference of Tumor Evolution during Chemotherapy by Computational Modeling and In Situ Analysis of Genetic and Phenotypic Cellular DiversityVanessa Almendro, Kornélia Polyák, Yu-Kang Cheng et al.|Cell Reports|2014Cited by 283
Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trialAleix Prat, Joaquín Gavilá, Montserrat Muñoz-Mateu et al.|The Lancet Oncology|2019Cited by 199